Medtronic PLC vs Vanguard Dividend Appreciation Index Fund ETF — how do they compare? Medtronic PLC trades at $87.9 (market cap $109.38B), while Vanguard Dividend Appreciation Index Fund ETF trades at $237.41 (market cap $132.40B). The key difference: Vanguard Dividend Appreciation Index Fund ETF is the larger of the two by market cap, and Medtronic PLC pays a 3.37% dividend while Vanguard Dividend Appreciation Index Fund ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Vanguard Dividend Appreciation Index Fund ETF for 133 Days on average.
| MDT | VIG | |
|---|---|---|
Market Cap | $109.38B | $132.40B |
Volume | 55,890,185 | 1,733,469 |
Sector | Health | — |
52-Week High | $105.35 | $246.61 |
52-Week Low | $73.75 | $210.70 |
Typical Hold Time | 63 Days | 133 Days |
Enterprise Value | $128.71B | — |
Dividend Yield | 3.37% | — |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $85.51, down 1.81% on the day, showing bearish technical signals despite strong fundamental performance. The company has beaten earnings estimates for three consecutive quarters with Q3 2026 results pending, while maintaining robust profitability margins of 65% gross and 14% net. Recent news highlights the company's 49-year dividend growth streak and new product approvals, though technical indicators show selling pressure with the stock trading near support at $85.
MDT presents a compelling value opportunity with a 3.2% dividend yield and 14% upside to the $97.80 consensus target, though near-term technical weakness and increasing debt levels warrant caution. The company's consistent earnings beats and medical device market leadership support long-term growth, while regulatory approvals for new systems provide catalysts.
VIG trades at $236.99, down 0.32% on the day, with technical indicators showing a bullish trend supported by moving averages. The ETF focuses on dividend growth companies with at least 10 consecutive years of dividend increases, offering a lower yield but stronger growth profile compared to peers. Recent news highlights VIG's 7.5% quarterly dividend increase and its strategic positioning for long-term income investors.
VIG presents a compelling option for investors seeking dividend growth with moderate risk, though its low current yield may not suit income-focused portfolios. Key risks include market volatility and the ETF's exclusion of high-yield dividend payers. Analyst sentiment remains positive given its historical 10% annual returns and quality screening criteria.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that have a record of increasing dividends over time. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VIG →